HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Gender-Specific Cancers: Gynecologic cancers, Prostate cancer.

Gender-Specific Cancers: Gynecologic cancers, Prostate cancer.

Gender-specific cancers require tailored research to address the unique needs of men and women. Gynecologic cancers, including cervical, ovarian, and uterine cancers, benefit from advancements in HPV vaccines, minimally invasive surgeries, and targeted therapies. Prostate cancer research focuses on improving outcomes through advanced imaging, androgen deprivation therapy, and precision medicine approaches. Gender-based differences in cancer biology, treatment responses, and survivorship experiences are integral to developing effective strategies. Collaborative studies and patient-centered care models aim to enhance treatment efficacy while addressing quality-of-life concerns.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Atif A Ahmed

Atif A Ahmed

Seattle Children’s Hospital, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
CIOC 2027 Speakers
Thomas Jay Webster

Thomas Jay Webster

Brown University, United States
Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece
Saumya Pandey

Saumya Pandey

Indira IVF Hospital, India

Submit your abstract Today

YouTube
WhatsAppWhatsApp